These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21407827)

  • 1. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
    Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
    PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards in silico oncology: adapting a four dimensional nephroblastoma treatment model to a clinical trial case based on multi-method sensitivity analysis.
    Georgiadi ECh; Dionysiou DD; Graf N; Stamatakos GS
    Comput Biol Med; 2012 Nov; 42(11):1064-78. PubMed ID: 23063290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'In silico' oncology for clinical decision making in the context of nephroblastoma.
    Graf N; Hoppe A; Georgiadi E; Belleman R; Desmedt C; Dionysiou D; Erdt M; Jacques J; Kolokotroni E; Lunzer A; Tsiknakis M; Stamatakos G
    Klin Padiatr; 2009; 221(3):141-9. PubMed ID: 19437361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumor to chemotherapy: Mimicking a clinical study.
    Stamatakos GS; Kolokotroni EA; Dionysiou DD; Georgiadi ECh; Desmedt C
    J Theor Biol; 2010 Sep; 266(1):124-39. PubMed ID: 20515697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico oncology: exploiting clinical studies to clinically adapt and validate multiscale oncosimulators.
    Stamatakos GS; Kolokotroni E; Dionysiou D; Veith C; Kim YJ; Franz A; Marias K; Sabczynski J; Bohle R; Graf N
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5545-9. PubMed ID: 24110993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
    Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
    Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "Oncosimulator": a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology.
    Stamatakos GS; Dionysiou DD; Graf NM; Sofra NA; Desmedt C; Hoppe A; Uzunoglu NK; Tsiknakis M
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6629-32. PubMed ID: 18003545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and changes in the treatment of children with nephroblastoma.
    Pietras W
    Adv Clin Exp Med; 2012; 21(6):809-820. PubMed ID: 23457141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.
    Weirich A; Leuschner I; Harms D; Vujanic GM; Tröger J; Abel U; Graf N; Schmidt D; Ludwig R; Voûte PA
    Ann Oncol; 2001 Mar; 12(3):311-9. PubMed ID: 11332141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context.
    Stamatakos G; Dionysiou D; Lunzer A; Belleman R; Kolokotroni E; Georgiadi E; Erdt M; Pukacki J; Rüeping S; Giatili S; d'Onofrio A; Sfakianakis S; Marias K; Desmedt C; Tsiknakis M; Graf N
    IEEE J Biomed Health Inform; 2014 May; 18(3):840-54. PubMed ID: 24108720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
    Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
    Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial.
    Lemerle J; Voute PA; Tournade MF; Rodary C; Delemarre JF; Sarrazin D; Burgers JM; Sandstedt B; Mildenberger H; Carli M
    J Clin Oncol; 1983 Oct; 1(10):604-9. PubMed ID: 6321673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cystic nephroma and cystic partially differentiated nephroblastoma--a report from the SIOP/GPOH study group.
    Luithle T; Szavay P; Furtwängler R; Graf N; Fuchs J;
    J Urol; 2007 Jan; 177(1):294-6. PubMed ID: 17162067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilms' tumor].
    Graf N
    Praxis (Bern 1994); 1996 Jun; 85(23):753-61. PubMed ID: 8693243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consultation within the nephroblastoma trial SIOP 2001/GPOH as part of the workload in the trial office.
    Zils K; Furtwängler R; Reinhard H; Alkassar M; Graf N
    Klin Padiatr; 2008; 220(3):183-8. PubMed ID: 18478492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH.
    Marx M; Langer T; Graf N; Hausdorf G; Stöhr W; Ludwig R; Beck JD
    Med Pediatr Oncol; 2002 Jul; 39(1):18-24. PubMed ID: 12116074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH.
    Ludwig R; Weirich A; Abel U; Hofmann W; Graf N; Tournade MF
    Med Pediatr Oncol; 1999 Nov; 33(5):462-9. PubMed ID: 10531570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resection of nephroblastoma: problems and complications--evaluation of the Nephroblastoma Study SIOP 9/GPOH].
    Roth H; Weirich A; Ludwig R; Daum R; Zimmermann H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1078-83. PubMed ID: 9101785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.